Publikationen, an denen er mitarbeitet María Piñeiro Lamas (33)

2024

  1. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

    Inflammopharmacology, Vol. 32, Núm. 3, pp. 1805-1815

  2. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546

  3. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study

    International Journal of Neuropsychopharmacology, Vol. 27, Núm. 4

  4. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  5. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

2023

  1. Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 2

  2. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  3. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  4. Magnitude and determinants of inappropriate prescribing of antibiotics in dentistry: a nation-wide study

    Antimicrobial Resistance and Infection Control, Vol. 12, Núm. 1

  5. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  6. RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology

  7. Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

    European Neuropsychopharmacology, Vol. 71, pp. 96-108

2022

  1. Assessment of Potentially Inappropriate Medications Using the EU (7)-PIM List, in a Sample of Portuguese Older Adults’ Residents in Nursing Homes

    Risk Management and Healthcare Policy, Vol. 15, pp. 1343-1352

  2. Impact of the COVID-19 Pandemic on Antibiotic Prescribing by Dentists in Galicia, Spain: A Quasi-Experimental Approach

    Antibiotics, Vol. 11, Núm. 8

  3. Impact on In- and Out-of-Hospital Drug Prescriptions of Including a More Expensive Me-Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study

    Pharmacoepidemiology and Drug Safety, Vol. 31, Núm. 5, pp. 556-565

  4. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  2. Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria

    Frontiers in Pharmacology, Vol. 12

  3. The impact of the covid‐19 pandemic on antibiotic prescribing trends in outpatient care: A nationwide, quasi‐experimental approach

    Antibiotics, Vol. 10, Núm. 9

2020

  1. Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)

    Frontiers in Pharmacology